Table 2 Generalized linear model of the association between objective cognitive function and inflammation, metabolic disruption and BMI in individuals with post-COVID-19 condition
Model | B | Coefficients Standard Error | 95% Confidence Interval (CI) | Â | |
|---|---|---|---|---|---|
Lower | Upper | P value | |||
Age | -0.016 | 0.0089 | -0.033 | 0.002 | 0.081 |
Sex | -0.136 | 0.2403 | -0.607 | 0.335 | 0.571 |
Education | 0.102 | 0.0977 | -0.089 | 0.294 | 0.296 |
CRP | -2.248* | 0.9492 | -4.108 | -0.388 | 0.018 |
TG-HDL | -2.123** | 0.7641 | -3.621 | -0.626 | 0.005 |
BMI | -0.253** | 0.0972 | -0.444 | -0.063 | 0.009 |
TG-HDLxBMIxCRP | -0.021* | 0.0091 | -0.038 | -0.003 | 0.023 |
Suspected vs. Confirmed COVID-19 | 0.176 | 0.2867 | -0.386 | 0.738 | 0.540 |
QIDS-SR-16 | 0.046 | 0.0294 | -0.011 | 0.104 | 0.117 |
MDD Diagnosis | 0.163 | 0.2514 | -0.329 | 0.656 | 0.516 |
Fatigue | -0.047** | 0.0124 | -0.071 | -0.022 | < 0.001 |
Alcohol Consumption (Drinks per Week) | -0.035 | 0.0330 | -0.100 | 0.030 | 0.289 |
Marijuana Frequency | -0.171* | 0.0708 | -0.310 | -0.033 | 0.015 |